ILSI Brazil International Workshop on Functional Foods: A narrative review of the scientific evidence in the area of carbohydrates, microbiome, and health

Food and Nutrition Research

Volumn 57, Issue , 2013, Pages

  Latulippe, Marie E ^a   Meheust, Agnès ^a   Augustin, Livia ^b   Benton, David ^c   Berčík, Přemysl ^d   Birkett, Anne ^e   Eldridge, Alison L ^f   Faintuch, Joel ^g   Hoffmann, Christian ^h,i   Miller Jones, Julie ^j   Kendall, Cyril ^b   Lajolo, Franco ^g   Perdigon, Gabriela ^k   Prieto, Pedro Antonio ^l   Rastall, Robert A ^m   Sievenpiper, John L ^d   Slavin, Joanne ⁿ   De Menezes, Elizabete Wenzel ^g   Berezovsky, Mariela ^o  

^a International Life Sciences Institute of Europe   (Belgium)

^b UNIVERSITY OF TORONTO   (Canada)

^c SWANSEA UNIVERSITY   (United Kingdom)

^d MCMASTER UNIVERSITY   (Canada)

^e KELLOGG COMPANY   (United States)

^f NESTLÉ RESEARCH CENTER   (Switzerland)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^j ST CATHERINE UNIVERSITY   (United States)

^k UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

^l ABBOTT LABORATORIES   (United States)

^m UNIVERSITY OF READING   (United Kingdom)

ⁿ UNIVERSITY OF MINNESOTA   (United States)

^o ILSI Brazil   (Brazil)

more..

Author keywords

Biomarkers; Carbohydrates; Cognition; Fiber; Fructose; Functional food; Glycemia; Gut health; Microbiome; Mood; Prebiotic; Satiety; Weight

Indexed keywords

CARBOHYDRATE; FRUCTOSE; FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; GLUCOSE; INSULIN; INULIN; LIPOTEICHOIC ACID; PREBIOTIC AGENT; URIC ACID;

BODY WEIGHT; BRAZIL; CARBOHYDRATE DIET; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; COGNITION; DIABETES MELLITUS; DIETARY FIBER; FERMENTATION; FOOD; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; GLYCEMIC LOAD; HELICOBACTER PYLORI; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLORA; ISCHEMIC HEART DISEASE; LACTOBACILLUS CASEI; MEMORY; MICROBIOME; MOOD; NONHUMAN; OBESITY; REVIEW; SATIETY; TRICHURIS MURIS;

EID: 84874734142     PISSN: 16546628     EISSN: None     Source Type: Journal    
DOI: 10.3402/fnr.v57i0.19214     Document Type: Review

References (169)

1. Carbohydrates in Human Nutrition (1998). Report of a Joint FAO/WHO Expert Consultation. FAO Food and Nutrition Paper 66. Rome, Italy: FAO, pp. 1-140.
2. Institute of Medicine of the National Academies. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington, DC: National Academies Press; 2002, pp. 339-61.
3. Health Canada. Policy for labelling and sdvertising of dietary fibre-containing food products. Ottawa, ON: Health Canada, Bureau of Nutritional Sciences, Food Directorate, Health Products and Food Branch; 2012.
4. American Association of Cereal Chemists (2001). Definition of dietary fiber: report of the dietary fiber definition committee to the board of directors of the American Association of Cereal Chemists. Cereal Foods World 6: 112-26.
5. European Commission. Commission Directive 2008/100/EC. Official Journal of the European Union 2008; 51: L285-9.
6. Codex Alimentarius Commission (2008). Report of the 30th Session of the Codex Committee on Nutrition and Foods for Special Dietary Uses, Cape Town, South Africa, 3-7 November, 2008; ALINORM 09/32/26. Rome, Italy: Codex Alimentarius Commission.
7. Codex Alimentarius Commission (2009). Report of the 31st Session of the Codex Committee on Nutrition and Foods for Special Dietary Uses, Düsseldorf, Germany, 2-6 November, 2009; ALINORM 09/32/26. Rome, Italy: Codex Alimentarius Commission.
8. Howlett JF, Betteridge VA, Champ M, Craig SA, Meheust A, Jones JM. The definition of dietary fiber - discussions at the Ninth Vahouny Fiber Symposium: building scientific agreement. Food Nutr Res 2010; 54: 5750, doi: 10.3402/fnr.v54i0.5750
9. Slavin JL. Position of the American Dietetic Association: health implications of dietary fiber. JAm Diet Assoc 2008; 108: 1716-31.
10. Institute of Medicine Food and Nutrition Board. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (Macronutrients). Washington, DC: Institute of Medicine; 2002.
11. Grabitske HA, Slavin JL. Gastrointestinal effects of low-digestible carbohydrates. Crit Rev Food Sci Nutr 2009; 49: 327-60.
12. Tucker LA, Thomas KS. Increasing total fiber intake reduces risk of weight and fat gains in women. J Nutr 2009; 139: 576-81.
13. Du H, van der AD, Boshuizen HC, Forouhi NG,Wareham NJ, Halkjaer J, et al. Dietary fiber and subsequent changes in body weight and waist circumference in European men and women. Am J Clin Nutr 2010; 91: 329-36.
14. Pereira MA, Ludwig DS. Dietary fiber and body-weight regulation. Observations and mechanisms. Pediatr Clin North Am 2001; 48: 969-80.
15. Flood-Obbagy JE, Rolls BJ. The effect of fruit in different forms on energy intake and satiety at a meal. Appetite 2009; 52: 416-22.
16. Anne MS, Welch RW, Barbara M, Livingstone E, McCourt M, Burns AA, et al. The effects of the fibre content and physical structure of carrots on satiety and subsequent intakes when eaten as part of a mixed meal. Br J Nutr 2006; 96: 587-95.
17. Scholz-Ahrens KE, Ade P, Marten B, Weber P, Timm W, Acil Y, et al. Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J Nutr 2007; 137: 838S-46S.
18. Macfarlane GT, Macfarlane S. Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol 2011; 45 Suppl: S120-7.
19. Wong JM, de SR, Kendall CW, Emam A, Jenkins DJ. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 2006; 40: 235-43.
20. US Department of Agriculture. Dietary guidelines for Americans. Washington, DC: US Government Printing Office; 2010.
21. Instituto Brasileiro de Geografia e Estatística (IBGE). Pesquisa de Orçamentos Familiares 2002/2003 (POF) - Aquisição alimentar domiciliar per capita, Brasil e grandes regiões. Rio de Janeiro: IBGE; 2004.
22. Instituto Brasileiro de Geografia e Estatística (IBGE). Pesquisa de Orçamentos Familiares 2008/2009 (POF) - Aquisição alimentar domiciliar per capita, Brasil e grandes regiões. Rio de Janeiro: IBGE; 2010.
23. Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM, et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 1981; 34: 362-6.
24. Livesey G, Taylor R, Hulshof T, Howlett J. Glycemic response and health-a systematic review and meta-analysis: relations between dietary glycemic properties and health outcomes. Am J Clin Nutr 2008; 87: 258S-68S.
25. Livesey G, Taylor R, Hulshof T, Howlett J. Glycemic response and health-a systematic review and meta-analysis: the database, study characteristics, and macronutrient intakes. Am J Clin Nutr 2008; 87: 223S-36S.
26. Sadler M. Food, glycaemic response and health. ILSI Europe Concise Monograph Series. Brussels, Belgium: ILSI Europe; 2011.
27. Wolever TM, Brand-Miller JC, Abernethy J, Astrup A, Atkinson F, Axelsen M, et al. Measuring the glycemic index of foods: interlaboratory study. Am J Clin Nutr 2008; 87: 247S-57S.
28. Atkinson FS, Foster-Powell K, Brand-Miller JC. International tables of glycemic index and glycemic load values: 2008. Diabetes Care 2008; 31: 2281-3.
29. Hollenbeck CB, Coulston AM, Reaven GM. Comparison of plasma glucose and insulin responses to mixed meals of high-, intermediate-, and low-glycemic potential. Diabetes Care 1988; 11: 323-9.
30. Monro JA, Shaw M. Glycemic impact, glycemic glucose equivalents, glycemic index, and glycemic load: definitions, distinctions, and implications. Am J Clin Nutr 2008; 87: 237S-43S.
31. Jenkins DJ, Kendall CW, Mckeown-Eyssen G, Josse RG, Silverberg J, Booth GL, et al. Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA 2008; 300: 2742-53.
32. Larsen TM, Dalskov S, van BM, Jebb S, Kafatos A, Pfeiffer A, et al. The Diet, Obesity and Genes (Diogenes) Dietary Study in eight European countries - a comprehensive design for long-term intervention. Obes Rev 2010; 11: 76-91.
33. Burkitt DP, Trowell HC. Effects of fructo-oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon carcinogenesis in healthy humans. Refined carbohydrate foods and disease. New York: Academic Press; 1975.
34. Brand-Miller J, Hayne S, Petocz P, Colagiuri S. Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials. Diabetes Care 2003; 26: 2261-7.
35. Sheard NF, Clark NG, Brand-Miller JC, Franz MJ, Pi-Sunyer FX, Mayer-Davis E, et al. Dietary carbohydrate (amount and type) in the prevention and management of diabetes: a statement by the American Diabetes Association. Diabetes Care 2004; 27: 2266-71.
36. Levitan EB, Song Y, Ford ES, Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 2004; 164: 2147-55.
37. Lawes CM, Parag V, Bennett DA, Suh I, Lam TH, Whitlock G, et al. Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care 2004; 27: 2836-42.
38. Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr 2002; 75: 492-8.
39. Frost G, Leeds AA, Dore CJ, Madeiros S, Brading S, Dornhorst A. Glycaemic index as a determinant of serum HDL-cholesterol concentration. Lancet 1999; 353: 1045-8.
40. Franceschi S, Dal ML, Augustin L, Negri E, Parpinel M, Boyle P, et al. Dietary glycemic load and colorectal cancer risk. Ann Oncol 2001; 12: 173-8.
41. Augustin LS, Dal ML, La VC, Parpinel M, Negri E, Vaccarella S, et al. Dietary glycemic index and glycemic load, and breast cancer risk: a case-control study. Ann Oncol 2001; 12: 1533-8.
42. Augustin LS, Galeone C, Dal ML, Pelucchi C, Ramazzotti V, Jenkins DJ, et al. Glycemic index, glycemic load and risk of prostate cancer. Int J Cancer 2004; 112: 446-50.
43. Barclay AW, Petocz P, McMillan-Price J, Flood VM, Prvan T, Mitchell P, et al. Glycemic index, glycemic load, and chronic disease risk-a meta-analysis of observational studies. Am J Clin Nutr 2008; 87: 627-37.
44. Opperman AM, Venter CS, Oosthuizen W, Thompson RL, Vorster HH. Meta-analysis of the health effects of using the glycaemic index in meal-planning. Br J Nutr 2004; 92: 367-81.
45. Bornet FR, Jardy-Gennetier AE, Jacquet N, Stowell J. Glycaemic response to foods: impact on satiety and longterm weight regulation. Appetite 2007; 49: 535-53.
46. Ludwig DS, Majzoub JA, Al-Zahrani A, Dallal GE, Blanco I, Roberts SB. High glycemic index foods, overeating, and obesity. Pediatrics 1999; 103: E26.
47. Thomas DE, Elliott EJ, Baur L. Low glycaemic index or low glycaemic load diets for overweight and obesity. Cochrane Database Syst Rev 2007; 18(3), CD005105.
48. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003; 290: 486-94.
49. The DECODE study group on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999; 354: 617-21.
50. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233-40.
51. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA. beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 2005; 90: 493-500.
52. Chiu CJ, Milton RC, Gensler G, Taylor A. Association between dietary glycemic index and age-related macular degeneration in nondiabetic participants in the Age-Related Eye Disease Study. Am J Clin Nutr 2007; 86: 180-8.
53. Chiu CJ, Morris MS, Rogers G, Jacques PF, Chylack LT, Jr, Tung W, et al. Carbohydrate intake and glycemic index in relation to the odds of early cortical and nuclear lens opacities. Am J Clin Nutr 2005; 81: 1411-6.
54. Chiu CJ, Hubbard LD, Armstrong J, Rogers G, Jacques PF, Chylack LT, Jr, et al. Dietary glycemic index and carbohydrate in relation to early age-related macular degeneration. Am J Clin Nutr 2006; 83: 880-6.
55. Gilbertson HR, Brand-Miller JC, Thorburn AW, Evans S, Chondros P, Werther GA. The effect of flexible low glycemic index dietary advice versus measured carbohydrate exchange diets on glycemic control in children with type 1 diabetes. Diabetes Care 2001; 24: 1137-43.
56. Blundell J, de GC, Hulshof T, Jebb S, Livingstone B, Lluch A, et al. Appetite control: methodological aspects of the evaluation of foods. Obes Rev 2010; 11: 251-70.
57. Hetherington MM, Regan MF. Effects of chewing gum on short-term appetite regulation in moderately restrained eaters. Appetite 2011; 57: 475-82.
58. Hogenkamp PS, Stafleu A, Mars M, Brunstrom JM, de GC. Texture, not flavor, determines expected satiation of dairy products. Appetite 2011; 57: 635-41.
59. Marciani L, Gowland PA, Spiller RC, Manoj P, Moore RJ, Young P, et al. Effect of meal viscosity and nutrients on satiety, intragastric dilution, and emptying assessed by MRI. Am J Physiol Gastrointest Liver Physiol 2001; 280: G1227-33.
60. Samra RA, Anderson GH. Insoluble cereal fiber reduces appetite and short-term food intake and glycemic response to food consumed 75 min later by healthy men. Am J Clin Nutr 2007; 86: 972-9.
61. Holt SH, Miller JC, Petocz P, Farmakalidis E. A satiety index of common foods. Eur J Clin Nutr 1995; 49: 675-90.
62. Ranawana V, Henry CJ. Liquid and solid carbohydrate foods: comparative effects on glycemic and insulin responses, and satiety. Int J Food Sci Nutr 2011; 62: 71-81.
63. de Graaf C. Texture and satiation: the role of oro-sensory exposure time. Physiol Behav 2012; 107(4): 496-501
64. Wanders AJ, van den Borne JJ, de GC, Hulshof T, Jonathan MC, Kristensen M, et al. Effects of dietary fibre on subjective appetite, energy intake and body weight: a systematic review of randomized controlled trials. Obes Rev 2011; 12: 724-39.
65. European Food Safety Authority. Statement on the safety of synthetic zeaxanthin as an ingredient in food supplements. EFSA J 2012; 10: 2891.
66. European Food Safety Authority. Scientific opinion on the substantiation of health claims related to dietary fibre (ID 744, 745, 746, 748, 749, 753, 803, 810, 855, 1415, 1416, 4308, 4330) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J 2010; 8: 1735.
67. Benton D, Owens D. Is raised blood glucose associated with the relief of tension? J Psychosom Res 1993; 37: 723-35.
68. Nabb SL, Benton D. The effect of the interaction between glucose tolerance and breakfasts varying in carbohydrate and fibre on mood and cognition. Nutr Neurosci 2006; 9: 161-8.
69. Benton D, Brock H. Mood and the macro-nutrient composition of breakfast and the mid-day meal. Appetite 2010; 55: 436-40.
70. de Castro JM. Macronutrient relationships with meal patterns and mood in the spontaneous feeding behavior of humans. Physiol Behav 1987; 39: 561-9.
71. Wolraich ML, Wilson DB, White JW. The effect of sugar on behavior or cognition in children. A meta-analysis. JAMA 1995; 274: 1617-21.
72. Benton D. Sucrose and behavioral problems. Crit Rev Food Sci Nutr 2008; 48: 385-401.
73. Benton D, Stevens MK. The influence of a glucose containing drink on the behavior of children in school. Biol Psychol 2008; 78: 242-5.
74. Milazzo W, Fielder J, Bittel A, Coil J, McClure M, Tobin P, et al. Oral sucrose to decrease pain associated with arterial puncture in infants 30 to 36 weeks' gestation: a randomized clinical trial. Adv Neonatal Care 2011; 11: 406-11.
75. Willner P, Benton D, Brown E, Cheeta S, Davies G, Morgan J, et al. "Depression" increases "craving" for sweet rewards in animal and human models of depression and craving. Psychopharmacology (Berl) 1998; 136: 272-83.
76. Benton D, Maconie A, Williams C. The influence of the glycaemic load of breakfast on the behaviour of children in school. Physiol Behav 2007; 92: 717-24.
77. Wolever TM, Vuksan V, Eshuis H, Spadafora P, Peterson RD, Chao ES, et al. Effect of method of administration of psyllium on glycemic response and carbohydrate digestibility. J Am Coll Nutr 1991; 10: 364-71.
78. Bjorck I, Elmstahl HL. The glycaemic index: importance of dietary fibre and other food properties. Proc Nutr Soc 2003; 62: 201-6.
79. Pineiro M, Asp NG, Reid G, Macfarlane S, Morelli L, Brunser O, et al. FAO Technical meeting on prebiotics. J Clin Gastroenterol 2008; 42(Suppl 3): S156-9.
80. Food and Agriculture Organization of the United Nations WHO (2001). Report of a joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Rome, Italy: FAO/WHO.
81. Guarner F, Malagelada Jr. Gut flora in health and disease. Lancet 2003; 361: 512-9.
82. Gibson GR, Scott KP, Rastall RA, Tuohy KM, Hotchkiss A, Dubert-Ferrandon A. Dietary prebiotics: current status and new definition. Food Sci Technol Bull: Functional Foods 2010; 7: 1-19.
83. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995; 125: 1401-12.
84. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr 2010; 104(Suppl 2): S1-63.
85. Sela DA, Mills DA. Nursing our microbiota: molecular linkages between bifidobacteria and milk oligosaccharides. Trends Microbiol 2010; 18: 298-307.
86. Bode L. Human milk oligosaccharides: prebiotics and beyond. Nutr Rev 2009; 67(Suppl 2): S183-91.
87. de Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 2008; 111: 1-66.
88. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004; 79: 537-43.
89. Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, et al. Nutrition recommendations and interventions for diabetes-2006: a position statement of the American Diabetes Association. Diabetes Care 2006; 29: 2140-57.
90. Johnson RK, Appel LJ, Brands M, Howard BV, Lefevre M, Lustig RH, et al. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation 2009; 120: 1011-20.
91. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: http://www.cochrane-handbook.org.
92. Lewis GF, Uffelman K, Naples M, Szeto L, Haidari M, Adeli K. Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster. Endocrinology 2005; 146: 247-55.
93. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288: 1723-7.
94. Vuilleumier S. Worldwide production of high-fructose syrup and crystalline fructose. Am J Clin Nutr 1993; 58: 733S-6S.
95. Swarbrick MM, Stanhope KL, Elliott SS, Graham JL, Krauss RM, Christiansen MP, et al. Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women. Br J Nutr 2008; 100: 947-52.
96. Stanhope KL, Bremer AA, Medici V, Nakajima K, Ito Y, Nakano T, et al. Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women. J Clin Endocrinol Metab 2011; 96: E1596-605.
97. Stanhope KL, Havel PJ. Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup. Am J Clin Nutr 2008; 88: 1733S-7S.
98. Cox CL, Stanhope KL, Schwarz JM, Graham JL, Hatcher B, Griffen SC, et al. Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight/obese men and women. Eur J Clin Nutr 2012; 66: 201-8.
99. Murray RK, Granner DK, Mayes PA, Rodwell VW. Harper's illustrated biochemistry. New York: McGraw-Hill; 2006.
100. Brunengraber DZ, McCabe BJ, Kasumov T, Alexander JC, Chandramouli V, Previs SF. Influence of diet on the modeling of adipose tissue triglycerides during growth. Am J Physiol Endocrinol Metab 2003; 285: E917-25.
101. Lee WN, Bassilian S, Ajie HO, Schoeller DA, Edmond J, Bergner EA, et al. In vivo measurement of fatty acids and cholesterol synthesis using D2O and mass isotopomer analysis. Am J Physiol 1994; 266: E699-708.
102. Leveille GA. In vivo fatty acid synthesis in adipose tissue and liver of meal-fed rats. Proc Soc Exp Biol Med 1967; 125: 85-8.
103. Sievenpiper JL, de Souza RJ, Kendall CW, Jenkins DJ. Is fructose a story of mice but not men? J Am Diet Assoc 2011; 111: 219-20.
104. Petersen KF, Laurent D, Yu C, Cline GW, Shulman GI. Stimulating effects of low-dose fructose on insulin-stimulated hepatic glycogen synthesis in humans. Diabetes 2001; 50: 1263-8.
105. Hawkins M, Gabriely I, Wozniak R, Vilcu C, Shamoon H, Rossetti L. Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes. Diabetes 2002; 51: 606-14.
106. Marriott BP, Cole N, Lee E. National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J Nutr 2009; 139: 1228S-35S.
107. Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2011; 123: 2292-333.
108. Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008; 31(Suppl 1): S61-78.
109. Sievenpiper JL, Carleton AJ, Chatha S, Jiang HY, de Souza RJ, Beyene J, et al. Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: systematic review and meta-analysis of experimental trials in humans. Diabetes Care 2009; 32: 1930-7.
110. Ha V, Sievenpiper JL, de Souza RJ, Chiavaroli L, Wang DD, Cozma AI, et al. Effect of fructose on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Hypertension 2012; 59: 787-95.
111. Wang DD, Sievenpiper JL, de Souza RJ, Chiavaroli L, Ha V, Cozma AI, et al. The effects of fructose intake on serum uric acid vary among controlled dietary trials. J Nutr 2012; 142: 916-23.
112. Sievenpiper JL, de Souza RJ, Mirrahimi A, Yu ME, Carleton AJ, Beyene J, et al. Effect of fructose on body weight in controlled feeding trials: a systematic review and metaanalysis. Ann Intern Med 2012; 156: 291-304.
113. Cozma AI, Sievenpiper JL, de Souza RJ, Chiavaroli L, Ha V, Wang DD, et al. Effect of fructose on glycemic control in diabetes: a systematic review and meta-analysis of controlled feeding trials. Diabetes Care 2012; 35: 1611-20.
114. Livesey G, Taylor R. Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: metaanalyses and meta-regression models of intervention studies. Am J Clin Nutr 2008; 88: 1419-37.
115. Perez-Pozo SE, Schold J, Nakagawa T, Sanchez-Lozada LG, Johnson RJ, Lillo JL. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes (Lond) 2010; 34: 454-61.
116. Scientific concepts of functional foods in Europe. Consensus document. Br J Nutr 1999; 81(Suppl 1): S1-27.
117. Aggett PJ, Antoine JM, Asp NG, Bellisle F, Contor L, Cummings JH, et al. PASSCLAIM: consensus on criteria. Eur J Nutr 2005; 44(Suppl 1): i5-30.
118. Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods. OJ L 404, 2006; 30.12.2006. 9.
119. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69: 89-95.
120. Micheel C. Evaluation of biomarkers and surrogate endpoints in chronic disease. Washington, DC: National Academy Press; 2010.
121. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008; 8: 411-20.
122. Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 2012; 148: 1258-70.
123. Galdeano CM, Perdigon G. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin Vaccine Immunol 2006; 13: 219-26.
124. Galdeano CM, de Moreno de LA, Vinderola G, Bonet ME, Perdigon G. Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin Vaccine Immunol 2007; 14: 485-92.
125. Galdeano CM, Perdigon G. Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulation. J Appl Microbiol 2004; 97: 673-81.
126. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001; 292: 1115-8.
127. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006; 124: 837-48.
128. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science 2009; 326: 1694-7.
129. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134: 577-94.
130. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005; 102: 11070-5.
131. Scanlan PD, Shanahan F, Clune Y, Collins JK, O'Sullivan GC, O'Riordan M, et al. Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol 2008; 10: 789-98.
132. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004; 4: 478-85.
133. Faith JJ, McNulty NP, Rey FE, Gordon JI. Predicting a human gut microbiota's response to diet in gnotobiotic mice. Science 2011; 333: 101-4.
134. Arumugam M, Raes J, Pelletier E, Le PD, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature 2011; 473: 174-80.
135. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334: 105-8.
136. Sanz ML, Gibson GR, Rastall RA. Influence of disaccharide structure on prebiotic selectivity in vitro. J Agric Food Chem 2005; 53: 5192-9.
137. Sarbini SR, Kolida S, Naeye T, Einerhand A, Brison Y, Remaud-Simeon M, et al. In vitro fermentation of linear and alpha-1,2-branched dextrans by the human fecal microbiota. Appl Environ Microbiol 2011; 77: 5307-15.
138. Onumpai C, Kolida S, Bonnin E, Rastall RA. Microbial utilization and selectivity of pectin fractions with various structures. Appl Environ Microbiol 2011; 77: 5747-54.
139. Rastall RA. Functional oligosaccharides: application and manufacture. Annu Rev Food Sci Technol 2010; 1: 305-39.
140. Rhoades J, Manderson K, Wells A, Hotchkiss AT, Jr., Gibson GR, Formentin K, et al. Oligosaccharide-mediated inhibition of the adhesion of pathogenic Escherichia coli strains to human gut epithelial cells in vitro. J Food Prot 2008; 71: 2272-7.
141. Shoaf K, Mulvey GL, Armstrong GD, Hutkins RW. Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infect Immun 2006; 74: 6920-8.
142. Sinclair HR, de SJ, Gibson GR, Rastall RA. Galactooligosaccharides (GOS) inhibit Vibrio cholerae toxin binding to its GM1 receptor. J Agric Food Chem 2009; 57: 3113-9.
143. Al-Lahham SH, Roelofsen H, Priebe M, Weening D, Dijkstra M, Hoek A, et al. Regulation of adipokine production in human adipose tissue by propionic acid. Eur J Clin Invest 2010; 40: 401-7.
144. Cani PD, Osto M, Geurts L, Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 2012; 3: 279-88.
145. Jumpertz R, Le DS, Turnbaugh PJ, Trinidad C, Bogardus C, Gordon JI, et al. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr 2011; 94: 58-65.
146. Tasse L, Bercovici J, Pizzut-Serin S, Robe P, Tap J, Klopp C, et al. Functional metagenomics to mine the human gut microbiome for dietary fiber catabolic enzymes. Genome Res 2010; 20: 1605-12.
147. Musso G, Gambino R, Cassader M. Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders. Curr Opin Lipidol 2010; 21: 76-83.
148. Clarke S, Murphy E, Nilaweera K, Ross P, Shanahan F, O'Toole PW. et al. The gut microbiota and its relationship to diet and obesity: new insights. Gut Microbes 2012; 3: 186-202
149. Xiong Y, Miyamoto N, Shibata K, Valasek MA, Motoike T, Kedzierski RM, et al. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc Natl Acad Sci USA 2004; 101: 1045-50.
150. Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007; 50: 2374-83.
151. Membrez M, Blancher F, Jaquet M, Bibiloni R, Cani PD, Burcelin RG, et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J 2008; 22: 2416-26.
152. Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 2009; 106: 2365-70.
153. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002; 122: 1140-56.
154. Mittermaier C, Dejaco C, Waldhoer T, Oefferlbauer-Ernst A, Miehsler W, Beier M, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 2004; 66: 79-84.
155. Addolorato G, Capristo E, Stefanini GF, Gasbarrini G. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol 1997; 32: 1013-21.
156. Andrews H, Barczak P, Allan RN. Psychiatric illness in patients with inflammatory bowel disease. Gut 1987; 28: 1600-4.
157. Renault PF, Hoofnagle JH, Park Y, Mullen KD, Peters M, Jones DB, et al. Psychiatric complications of long-term interferon alfa therapy. Arch Intern Med 1987; 147: 1577-80.
158. Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 2007; 21: 153-60.
159. Denicoff KD, Rubinow DR, Papa MZ, Simpson C, Seipp CA, Lotze MT, et al. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med 1987; 107: 293-300.
160. DuPont AW, DuPont HL. The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol 2011; 8: 523-31.
161. Gaykema RP, Goehler LE, Lyte M. Brain response to cecal infection with Campylobacter jejuni: analysis with Fos immunohistochemistry. Brain Behav Immun 2004; 18: 238-45.
162. Lyte M, Varcoe JJ, Bailey MT. Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation. Physiol Behav 1998; 65: 63-8.
163. Bercik P, Verdu EF, Foster JA, Lu J, Scharringa A, Kean I, et al. Role of gut-brain axis in persistent abnormal feeding behavior in mice following eradication of Helicobacter pylori infection. Am J Physiol Regul Integr Comp Physiol 2009; 296: R587-94.
164. Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 2010; 139: 2102-12.
165. Heijtz RD, Wang S, Anuar F, Qian Y, Bjorkholm B, Samuelsson A, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 2011; 108: 3047-52.
166. Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 2011; 23: 255-64, e119.
167. Bercik P, Denou E, Collins J, JacksonW, Lu J, Jury J, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011; 141: 599-609.
168. McCleary BV, DeVries JW, Rader JI, Cohen G, Prosky L, Mugford DC, et al. Determination of total dietary fiber (CODEX definition) by enzymatic-gravimetric
169. Giuntini EB, Menezes EW. Dietary fiber. Nutrient recognized functions. Sao Paulo, Brazil: ILSI Brasil; 2011.